List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
19 October 2015 | By Victoria White
Within the framework of the collaboration, Nuevolution will apply its drug discovery platform Chemetics to discover and advance drug candidates...
15 October 2015 | By Victoria White
As part of the collaboration, Novera will discover and develop novel therapeutic compounds identified through OICR's drug discovery programme...
15 October 2015 | By Victoria White
Researchers have determined that the protein GPR3 might play an important role in alleviating the cognitive deficits of 'amyloid plaques'...
In this application note, learn how the manual MFI 5000 performs accurate particle analysis for viscous protein therapeutics, offering size, count and morphology...
Rapid analysis, platform methods and easy method development make the iCE3 ideal for analyzing biologics...
Due to protein therapeutic complexity, techniques like isoelectric focusing have become indispensable tools in evaluating biologic preparations...
12 October 2015 | By Victoria White
The Dementia Consortium is a £3.5m drug discovery collaboration between Alzheimer’s Research UK, MRC Technology, Eisai, Lilly and now Astex...
Micro-Flow Imaging™ (MFI™) has new MVSS 4.0 software to classify particles across many biopharmaceutical samples easily and instantaneously...
12 October 2015 | By Victoria White
Lilly has announced plans to add 30,000 square feet to its research and development site at the Alexandria Centre for Life Science in New York...
In collaboration with Takeda, Micro-Flow Imaging with the Bot1 Autosampler automated manual methods for monitoring biopharmaceutical quality/safety...
Wes™ builds on over a decade of Simple Western development and makes running a Western even more simple...
Wes now analyzes proteins up to 440 kDa with the same Simple Western speed and data quality you’ve come to enjoy...
8 October 2015 | By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
